We investigated the PEGASUS-TIMI 54 trial criteria in a real life post-MI population.
Patients were categorized according to criteria used in PEGASUS trial.
We used data from a nationwide French registry including 3670 patients (FAST-MI).
Enrichment criteria used in PEGAGUS succeed in defining a high-risk population.
Age represents the most discriminant factor.